Related Experiment Video
Updated: Dec 21, 2025
08:42
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
4.9K
CUEDC2 controls osteoblast differentiation and bone formation via SOCS3-STAT3 pathway
Jung-Woo Kim1,2, Sin-Hye Oh1,2, Mi Nam Lee1,2
1Hard-Tissue Biointerface Research Center, School of Dentistry, Chonnam National University, Gwangju, 61186, Republic of Korea.
Cell Death & Disease
|May 13, 2020
Summary
The CUE domain-containing 2 (CUEDC2) protein regulates osteoblast differentiation and bone formation. Silencing CUEDC2 promotes bone regeneration by influencing the SOCS3-STAT3 pathway, offering a potential therapeutic strategy.
Area of Science:
- Molecular Biology
- Bone Biology
- Cell Signaling
Background:
- CUE domain-containing 2 (CUEDC2) is implicated in cell cycle, inflammation, and tumorigenesis.
- The role of CUEDC2 in osteoblast differentiation and bone regeneration is currently unknown.
- Understanding CUEDC2's function is crucial for bone biology and regenerative medicine.
Purpose of the Study:
- To investigate the role of CUEDC2 in osteogenesis and bone regeneration.
- To elucidate the molecular mechanisms by which CUEDC2 influences bone formation.
- To explore CUEDC2 as a potential therapeutic target for bone diseases.
Main Methods:
- Analysis of CUEDC2 expression in bone tissues during development and differentiation.
- In vitro studies involving overexpression and knockdown of CUEDC2 in osteogenic precursor cells.
- In vivo studies using ectopic bone formation and critical-size calvarial defect models.
- Investigation of CUEDC2's effect on the SOCS3-STAT3 signaling pathway.
Main Results:
- CUEDC2 expression decreases during bone development and BMP2-induced osteoblast differentiation.
- Overexpression of CUEDC2 suppresses osteogenic differentiation and bone parameters in vivo.
- Knockdown of CUEDC2 enhances osteoblast differentiation and promotes bone regeneration in vivo.
- CUEDC2 regulates osteogenesis by modulating SOCS3 protein stability and affecting STAT3 activation.
Conclusions:
- CUEDC2 acts as a negative regulator of osteoblast differentiation and bone formation.
- The SOCS3-STAT3 pathway is a key mechanism through which CUEDC2 exerts its effects.
- Targeting CUEDC2 presents a promising therapeutic strategy for bone regeneration and treating bone diseases.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
3.7K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.7K
01:24Bone Formation by Endochondral Ossification
7.7K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
7.7K
02:33Hedgehog Signaling Pathway
9.6K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
9.6K
01:16TGF - β Signaling Pathway
10.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.2K
01:29Bone Formation by Intramembranous Ossification
9.7K
Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
9.7K
03:14Notch Signaling Pathway
6.2K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.2K